CAM
BNTX icon

Close Asset Management’s BioNTech BNTX Stock Holding History

Close Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Hold
61
– – ﹤0.01% 243
2025
Q4 		$6K Hold
61
– – ﹤0.01% 238
2025
Q3 		$6K Buy
+61
New +$6.52K ﹤0.01% 241

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Close Asset Management's BNTX Position: Q1 2026 in Review

Close Asset Management held its BioNTech (BNTX) position steady in Q1 2026 at 61 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #243.

Close Asset Management first reported a position in BNTX in Q3 2025 and has held it in 3 quarters since. The position peaked at $6K in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Close Asset Management held 61 shares of BioNTech worth $5K as of Q1 2026.
  • Close Asset Management left its BioNTech share count unchanged in Q1 2026.
  • BioNTech made up ﹤0.01% of Close Asset Management's portfolio in Q1 2026, its #243 holding.
  • Close Asset Management first reported a position in BioNTech in Q3 2025 and has held it in 3 quarters since.
  • Close Asset Management's BioNTech position peaked at $6K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.